Table 1. Demographic Data of Patients in the Two Groups.

	Male/Female, Mean (SD)	INR before treatment. Mean (SD)	INR after treatment, Mean (SD)
Post-liver disease bleeding	9/7 (17 ± 5.4)	4 ± 0.3	1.4 ± 0.2
High INR candidate for surgery or biopsy	5/4 (18 ± 5.3)	4.3 ± 0.4	1.3 ± 0.1